Drawing for ENBIFELIX

USPTO serial 88258688

ENBIFELIX

Reviewed by CopyMark Law Group

Reg. 6669198Status 700Registered
Filing date
Status date
Registration date
Mar 15, 2022
Examiner
WATSON, BRIDGET ANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ENBIFELIX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritisACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Mar 15, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 28, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 28, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 8, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 15, 2021DOCKASSIGNED TO EXAMINER
Oct 13, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 25, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 8, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 15, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 14, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 11, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 11, 2019GNSLLETTER OF SUSPENSION E-MAILED
Jul 11, 2019CNSLSUSPENSION LETTER WRITTEN
Jul 6, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2019ALIEASSIGNED TO LIE
Jul 1, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 28, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 28, 2019GNSLLETTER OF SUSPENSION E-MAILED
Mar 28, 2019CNSLSUSPENSION LETTER WRITTEN
Mar 26, 2019DOCKASSIGNED TO EXAMINER
Feb 2, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 15, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance